Cireca delivers new insights into tumor and tissue composition by utilizing the interaction of mid-IR radiation with the biochemical components of tissue, including proteins, lipids, metabolites, and nucleic acids. The spatial variations of these tissue components are detected qualitatively and quantitatively and allow identification of tissue type, disease state, tumor heterogeneity and tissue microenvironment.
WITec is the leading German manufacturer of confocal and scanning-probe microscopes for Raman, Atomic Force (AFM), and Scanning Near-Field Optical Microscopy (SNOM). From the company’s founding in 1997, WITec has been distinguished by its innovative product portfolio and a microscope design that enables combinations of the various imaging techniques within one system. To this day, WITec’s confocal microscopes are unrivaled in sensitivity, resolution and imaging capabilities.
Agilent offers a comprehensive portfolio of innovative solutions – from improving lab productivity for chemical analysis, to vacuum systems, to workflow solutions developed to facilitate unlocking the complexities of living systems. We help you stay current with emerging applications and approved methods, while our integrated workflow solutions deliver accurate, comprehensive data helping you make informed decisions accelerating your time to results.
Agilent’s FTIR imaging systems and microscopes deliver superb imaging sensitivity at high spectral and spatial resolutions in applications such as measurement of live cells in water, and the determination of chemical changes in tissues without staining.
ClinSpec Diagnostics Ltd is a pre-spinout company based at the University of Strathclyde, who are developing the world’s first cost-effective blood test for the early detection of brain cancers. The current diagnostic pathway for brain cancers results in delayed diagnosis, contributing to the worst survival rates of any cancer. The ClinSpec Dx™ Triage ID system, using revolutionary SIRE Technology™, will allow clinicians to triage and fast-track patients for urgent brain scans. The technology is a platform for blood tests for other cancer and disease, as well as non-clinical applications, providing a pipeline of future products